Scott N Mlynarski

5PUBLICATIONS
68CO-AUTHORS
Haematological tumoursCheminformatics and quantitative structure-activity relationshipsBiologically active moleculesBiomolecular modelling and designApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 29, 2026
AZ'4331 is a novel pan-TEAD auto-palmitoylation inhibitor for the treatment of Hippo pathway-altered cancers.

|Sep 03, 2025
Discovery of AZD8421: A Potent CDK2 Inhibitor with Selectivity Against Other CDK Family Members and the Human Kinome.

Avipsa Ghosh, Afshan Ahmed, Konstantina Amoiradaki

|Nov 22, 2024
Discovery of (2R,4R)-4-((S)-2-Amino-3-methylbutanamido)-2-(4-boronobutyl)pyrrolidine-2-carboxylic Acid (AZD0011), an Actively Transported Prodrug of a Potent Arginase Inhibitor to Treat Cancer.

Scott N Mlynarski, Brian M Aquila, Susan Cantin

|Nov 14, 2024
Design and Synthesis of Acyclic Boronic Acid Arginase Inhibitors.

Jason D Shields, Brian M Aquila, David Emmons

|Mar 13, 2023
Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners.

Aatman S Doshi, Susan Cantin, Marylens Hernandez

Pageof 1

Frequent Collaborators

3 joint publications

M Raymond V Finlay

3 joint publications

Sharon Tentarelli

2 joint publications

Alwin G Schuller

2 joint publications

Clare Hoover